论文部分内容阅读
本文对丹参口服液护肝、降酶作用进行了实验和临床的研究。结果表明,丹参口服液能明显降低四氯化碳和醋氨酚肝毒剂量所致的小鼠 SGPT 升高,抑制肝细胞脂质过氧化反应,具有抗实验性肝损伤作用。临床应用丹参口服液治疗57例慢性乙型肝炎,具有明显降酶和改善病人症状等疗效,总有效率为77.1%。
This article has carried on the experiment and the clinical research to the hepatoprotective and the enzymatic action of Danshen Oral Liquid. The results showed that Salvia miltiorrhiza oral liquid can significantly reduce the hepatic toxin dose of carbon tetrachloride and acetaminophen to increase the SGPT in mice, inhibit the lipid peroxidation of hepatocytes, and have the effect of resisting experimental hepatic injury. The clinical application of Danshen Oral Liquid in the treatment of 57 cases of chronic hepatitis B has obvious efficacy in reducing the enzyme and improving the patient’s symptoms. The total effective rate is 77.1%.